Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Deutsche BKK to implement routine HPV testing for cervical cancer screening in Europe
February 9th, 2006
Europe's first cervical cancer screening program using routine human papilloma virus (HPV) testing will be implemented by Deutsche BKK, a major public-health insurance provider in central Germany, in partnership with the local gynecologists' association and a regional hospital, announced Digene Corp. (DIGE). The protocol adopted by BKK requires use of the Digene HPV Test, also marketed as the DNAwithPap Test. It is the only U.S. Food & Drug Administration-approved test for high-risk types of the human papilloma virus, which cause virtually all cases of cervical cancer. The test is approved in the United States for use along with the Pap to screen women age 30 and older,...
Source: Women's Health Weekly (2006-02-09)
|
